ATE214063T1 - Heterocyclische substituierte pyrrolidinamid- derivate - Google Patents

Heterocyclische substituierte pyrrolidinamid- derivate

Info

Publication number
ATE214063T1
ATE214063T1 AT97946443T AT97946443T ATE214063T1 AT E214063 T1 ATE214063 T1 AT E214063T1 AT 97946443 T AT97946443 T AT 97946443T AT 97946443 T AT97946443 T AT 97946443T AT E214063 T1 ATE214063 T1 AT E214063T1
Authority
AT
Austria
Prior art keywords
pyrrolidinamide
derivatives
heterocyclic substituted
heterocyclic
substituted
Prior art date
Application number
AT97946443T
Other languages
English (en)
Inventor
Thimothy P Burkholder
George D Maynard
Elizabeth M Kudlacz
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE214063T1 publication Critical patent/ATE214063T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT97946443T 1996-12-19 1997-11-03 Heterocyclische substituierte pyrrolidinamid- derivate ATE214063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76981296A 1996-12-19 1996-12-19
PCT/US1997/019884 WO1998027086A1 (en) 1996-12-19 1997-11-03 Novel heterocyclic substituted pyrrolidine amide derivatives

Publications (1)

Publication Number Publication Date
ATE214063T1 true ATE214063T1 (de) 2002-03-15

Family

ID=25086573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946443T ATE214063T1 (de) 1996-12-19 1997-11-03 Heterocyclische substituierte pyrrolidinamid- derivate

Country Status (20)

Country Link
EP (1) EP0946548B1 (de)
JP (1) JP4195512B2 (de)
KR (1) KR100514263B1 (de)
CN (1) CN1119344C (de)
AR (1) AR009665A1 (de)
AT (1) ATE214063T1 (de)
AU (1) AU723966B2 (de)
BR (1) BR9714057A (de)
CA (1) CA2275527C (de)
DE (1) DE69710921T2 (de)
DK (1) DK0946548T3 (de)
ES (1) ES2169881T3 (de)
HU (1) HUP0000315A3 (de)
IL (1) IL130223A (de)
NO (1) NO317760B1 (de)
NZ (1) NZ335975A (de)
PT (1) PT946548E (de)
TW (1) TW486477B (de)
WO (1) WO1998027086A1 (de)
ZA (1) ZA9711271B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
KR20040029375A (ko) * 2001-07-20 2004-04-06 화이자 프로덕츠 인코포레이티드 개, 고양이 및 말에서 결함있는 행태를 변화시키기 위한nk-1 수용체 길항제의 용도
AU2008290634B2 (en) 2007-08-22 2012-12-06 F. Hoffmann-La Roche Ag Pyrrolidine aryl-ether as NK3 receptor antagonists
WO2020089025A1 (en) 2018-10-29 2020-05-07 Boehringer Ingelheim International Gmbh Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
SG11202102440SA (en) 2018-10-29 2021-04-29 Boehringer Ingelheim Int Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
HU224496B1 (hu) * 1993-05-06 2005-10-28 Merrel Dow Pharmaceuticals Inc. Pirrolidin-3-il-alkil-piperidin-származékok és e vegyületeket tartalmazó gyógyászati készítmények
JPH11513991A (ja) * 1995-11-17 1999-11-30 ヘキスト・マリオン・ルセル・インコーポレイテツド アレルギー性疾患の治療に有用な置換4−(1h−ベンズイミダゾル−2−イル−アミノ)ピペリジン

Also Published As

Publication number Publication date
CA2275527C (en) 2003-09-23
HUP0000315A3 (en) 2002-01-28
EP0946548B1 (de) 2002-03-06
WO1998027086A1 (en) 1998-06-25
KR100514263B1 (ko) 2005-09-15
AR009665A1 (es) 2000-04-26
EP0946548A1 (de) 1999-10-06
DE69710921D1 (de) 2002-04-11
NO317760B1 (no) 2004-12-13
NZ335975A (en) 2000-11-24
HK1020947A1 (en) 2000-05-26
NO993013D0 (no) 1999-06-18
ES2169881T3 (es) 2002-07-16
DE69710921T2 (de) 2002-09-19
IL130223A0 (en) 2000-06-01
CN1119344C (zh) 2003-08-27
JP4195512B2 (ja) 2008-12-10
AU723966B2 (en) 2000-09-07
CN1241185A (zh) 2000-01-12
NO993013L (no) 1999-08-18
JP2001506650A (ja) 2001-05-22
PT946548E (pt) 2002-06-28
IL130223A (en) 2005-09-25
CA2275527A1 (en) 1998-06-25
ZA9711271B (en) 1998-06-19
DK0946548T3 (da) 2002-06-24
AU5160798A (en) 1998-07-15
KR20000057668A (ko) 2000-09-25
TW486477B (en) 2002-05-11
BR9714057A (pt) 2000-05-09
HUP0000315A2 (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
DK0901474T3 (da) Arylpyrimidinderivater
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
EE9900211A (et) Asendatud pürasooliderivaadid
BR9711262A (pt) Derivados 6,6 substituido hetero biciclicos
PT934320E (pt) Derivados de naftiridina
ATE235220T1 (de) Resorcinderivate
ATE260243T1 (de) N-aroylphenylalaninderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
EE9800219A (xx) Uued 19-nor-pregneeni derivaadid
NO981946D0 (no) Imidazoquinazolin-derivater
ATE255098T1 (de) Substituierte chromanderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
ATE255099T1 (de) Substituierte chromanderivate
FI955164A0 (fi) Heterosykliset johdannaiset
FI970110A7 (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
PT906279E (pt) Derivados de pirrol
PT931087E (pt) Novos derivados de piranosido
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
NO992526D0 (no) Cephalosporin-derivater
DE69710921D1 (de) Heterocyclische substituierte pyrrolidinamid-derivate
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
FI965181L (fi) Polyalkoholi-peptidijohdannaiset

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee